These conflicting results called into question the validity of localization of a QTL by linkage followed by the use of a congenic strain made with an incomplete chromosome coverage. To resolve this issue, we constructed five new congenic strains, designated C17S.L1 to C17S.L5, that completely spanned the Ϯ2 LOD confidence interval supposedly containing the QTL. Each congenic strain was made by replacing a segment of the DSS rat by that of the normotensive Lewis (LEW) rat. The only section to be LL homozygous is the region on Chr 17 specified in a congenic strain, as evidenced by a total genome scan. The results showed that BPs of C17S.L1 and C17S.L2 were lower (P Ͻ 0.04) than that of DSS rats. In contrast, BPs of C17S.L3, C17S.L4, and C17S.L5 were not different (P Ͼ 0.6) from that of DSS rats. Consequently, a BP QTL must be located in an interval of ϳ15 cM shared between C17S.L1 and C17S.L2 and unique to them both, as opposed to C17S.L3, C17S.L4, and C17S.L5. The present study illustrates the importance of thorough chromosome coverage, the necessity for a genome-wide screening, and the use of "negative" controls in physically mapping a QTL by congenic strains.
THE PRESENCE OF A BLOOD PRESSURE (BP) quantitative trait locus (QTL) on rat chromosome 17 (Chr 17) was originally hinted on by linkage analyses of an F2 population derived from a cross between the Dahl salt-sensitive (DSS) and Lewis (LEW) rats (6) . The maximum LOD score supporting this localization was 2.9, which constitutes a suggestive linkage (6) . Subsequently, another group of investigators using a different model of salt-sensitive hypertension, the Sabra strain, independently localized a QTL by linkage to a similar region, but with a higher LOD score of 3.43 (27) . Employing recombinant inbred strains derived from crosses between the spontaneously hypertensive (SHR) and Brown Norway (BN) rats (22) , a separate group of investigators did not find linkage to BP, but they found linkage to the left ventricular mass in a region on Chr 17 distant from the interval containing the BP QTL reported in DSS and Sabra rats (6, 27) . Recently, researchers studying cardiac hypertrophy associated with pulmonary hypertension (28) showed that a QTL for right ventricular mass was localized to a Chr 17 region close to the BP QTL in DSS (6) and Sabra (27) strains. Finally, linkage analysis based on the Lyon rats also showed that a QTL on Chr 17 was involved in controlling metabolic homeostasis and BP (3) .
Nevertheless, the BP QTL localization (6) was questioned because a congenic strain made by replacing a segment of the DSS chromosome with that of LEW did not show any BP effect (12) . Due to a lack of markers at the time, the entire Ϯ2 LOD support interval harboring the QTL was not replaced in that study (12) . Consequently, the validity of the QTL could not be verified.
For the convenience of presentation and discussion, the congenic strain previously made (12) is designated as congenic 1. Because congenic 1 was constructed on selecting certain Chr 17 markers alone and did not span fully the region supposed to harbor the QTL (12), the observed result using congenic 1 was not entirely unexpected. The present investigation was designed, first, to create congenic strains to cover, at minimum, the Ϯ2 LOD support interval harboring the QTL. Once a BP effect was demonstrated in the congenic strain by telemetry, congenic substrains were made to derive "negative" control congenic strains.
METHODS

Animals.
The SS/Jr rat used for making the congenic strain and substrains will be designated as DSS in the present report and is the same as we used previously (2, 7, 9, 10, (18) (19) (20) (21) 24) . LEW/CrlBR (LEW) rats were purchased from Charles Rivers Laboratories (La Salle, Quebec, Canada). Protocols for handling as well as maintaining animals were approved by our Institutional Animal Committee. All experimental procedures were in accordance with the guidelines of institutional, provincial, and federal regulations.
Breeding scheme for generating congenic strains. The breeding procedure, markers used for the total genome scan, and screening protocol were similar to those reported previously (2, 7, 18, 20, 21, 24) . From this process, two congenic strains were produced and are designated as DSS.LEW-(D17Rat65-Prl)/Lt (abbreviated as C17S.L1) and DSS.LEW-(D17Chm14/D17Rat181)/Lt (abbreviated as C17S.L2). C17 indicates that the strains are made for Chr 17.
Derivations of congenic substrains followed virtually the same procedure as those for Chr 10 (21). Briefly, rats of the DSS and C17S.L1 were cross-bred to produce F 1 rats, which then were intercrossed to produce F2 progeny. The F2 rats were genotyped with D17Rat65 and prolactin (Prl) (Fig. 1) to search for crossovers. Once a crossover was identified, other markers located between D17Rat65 and D17Rat83 were genotyped to define more precisely the crossover Article published online before print. See web site for date of publication (http://physiolgenomics.physiology.org).
breakpoints. Several rats with crossovers in the regions of interest were capable of breeding. Each of these rats was then backcrossed (BC) to a DSS rat to duplicate the fragment. Male and female heterozygous BC rats were intercrossed to derive progeny homozygous LL for the region of interest, and SS for the rest of the chromosome and the rest of the genome. This phenotype was reverified by genotyping Ͼ114 markers scattered throughout the rat genome, as was done for making C17S.L1. As a result, three congenic substrains were established. They were DSS.LEW-(D17Rat65/D17Chm2)/Lt (abbreviated as C17S.L3), DSS.LEW-(D17Chm9/D17Rat97)/Lt (abbreviated as C17S.L4), and DSS.LEW-(D17Chm14/D17Rat97)/Lt (abbreviated as C17S.L5) (Fig. 1) .
Production of new chromosome markers. Supercontigs located in Chr 17 regions of interest were first identified by blasting with a known marker at the website http://www.ncbi.nlm.nih.gov/genome/ seq/RnBlast.html. From such a supercontig, regions possessing microsatellites were searched and, when found, were used to design PCR-based markers for genotyping rats. According to the guideline on rat nomenclature (http://rgnc.gen.gu.se/Brief.html), these new markers ( Fig. 1) were designated with D17Chm prefixes, which represent CHUM.
BP measurements. The determination of BPs of the rats was, in principle, the same as described previously (2, 7, 9, 10, (18) (19) (20) (21) 24) . In brief, the mating pairs of the DSS and congenic strains to be studied were bred simultaneously. Male rats were selected and weaned at 21 days of age, maintained on a low-salt diet (0.2% NaCl; Harlan Teklad 7034), and then fed a high-salt diet (2% NaCl; Harlan Teklad 94217) starting at 35 days of age until the end of the experiment. Telemetry probes were implanted when rats were 56 days old (i.e., after 3 wk of the high-salt diet), with their body weights between 250 and 320 g. After the surgery, the rats were allowed 10 days to recuperate before their BPs were read. The implantation of telemetry probes, age, and postoperative care of animals are the same as described before (9, 10). The telemetry system from Data Sciences (St. Paul, MN) was used to measure BP. Each telemetry probe was calibrated before and cleaned after each usage, according to manufacturer's instructions.
BP studies. The basic design of raising animals is similar to our previous congenic work regarding age and sex and in terms of the time table of dietary treatments (2, 7, 9, 10, 18-21, 24). One BP reading was taken every 2 min for the period of measurement. Then, these readings were averaged for 24 h to obtain one data point, which appears as a point on the graph. Please see Dutil and Deng (9) for detailed comparisons of BPs of DSS and a congenic strain showing even finer reading variations during our typical BP measurements.
BPs for all the strains shown in the Fig. 1 were measured, at least, at two different times, i.e., they were separate litters raised at different time periods, for the purpose of excluding seasonal variations in the measurements (data not shown). BPs for all the strains were measured simultaneously each time. The results from these separate measurements were not different for each strain (P Ͼ 0.05) for pooling.
Statistical analysis. Repeated-measures ANOVA followed by the Dunnett test in the SYSTAT 9 program (SPSS Sci, Chicago, IL) was used to compare the significance level for a difference or a lack of it in a BP component between a congenic strain and the S strain. The Dunnett test takes into account multiple group comparisons as well as sample sizes among the comparing groups. In the analysis, a BP component was compared at each day for the period of measurement among the strains (2, 7, 9, 10, 18-21, 24).
RESULTS
Congenic constructions.
By following the strategy of selecting a BC rat at each generation, the construction of the first two congenic strains, C17S.L1 and C17S.L2, was accomplished in five, instead of eight or more, BC generations as used conventionally (1, 11, 12, 23, 26) . Current results are consistent with those of other investigators (17) and with the previous work of our laboratory (2, 7, (18) (19) (20) (21) 24) .
C17S.L1 was designed to cover, at minimum, the Ϯ2 LOD support interval for the QTL between D17Mit5 and D17Mit2 (6, 12) , although this coverage included a section of ambiguity between D17Chm55 and C17Mit2. C17S.L2 shared a segment of chromosome with C17S.L1. From C17S.L1, three substrains were derived (Fig. 1) .
In this process of screening crossovers to derive substrains from C17S.L1, nine rats with different crossovers between D17Rat66 and Prl were obtained. Three of them died or did not breed, and consequently no substrains could be derived from them. Three other rats gave rise to three congenic substrains, C17S.L3, C17S.L4, and C17S.L5. The remaining three rats had crossovers within the chromosome region contained in C17S.L4 (Fig. 1) . Because of a lack of an effect on BP in C17S.L4 (see below for detail), these last three rats were discarded.
Measurements of BP. Mean arterial (MAP), diastolic (DAP), and systolic (SAP) pressures of DSS rats and those of rats of congenic strains were measured. BPs for all the strains were not different at the separate periods of measurements (data not shown). Therefore, the BP data were pooled from reproducible measurements for each strain. Patterns of diurnal variations among the strains were not different (data not shown). For the simplicity of comparisons among the strains, MAPs were shown at the bottom of Fig. 1 . These numbers were given as averaged values throughout the days of measurements.
Mapping of a BP QTL. MAPs of C17S.L1 and C17S.L2 were lower (P Ͻ 0.04) than those of DSS (Fig. 1) . In contrast, MAPs of C17S.L3, C17S.L4, and C17S.L5 were not different (P Ͼ 0.68) from those of DSS (Fig. 1) . Therefore, all the congenic strains can be classified into two groups, i.e., group 1, which had a BP effect (i.e., C17S.L1 and C17S.L2), and group 2, which did not have a BP effect (i.e., C17S.L3, C17S.L4, and C17S.L5).
Because C17S.L1 (Fig. 1) showed a BP effect, a QTL has to be located in the region between D17Rat65 and D17Rat181 markers. The region containing the QTL can be further narrowed to the segment that was shared between C17S.L1 and C17S.L2 but not shared between group 1 and group 2 congenic strains (Fig. 1) . This means that the location of the QTL is between D17Rat97 and D17Rat181 markers. This interval is ϳ15 cM. The possibility cannot be excluded that another C17QTL could exist in the interval of 8.8 cM between D17Rat181 and D17Rat84, because C17S.L2 had a BP effect.
DISCUSSION
The major conclusion from the current work is that the BP QTL, which previously did not show to be present (12) , has now been proven to exist in a segment of ϳ15 cM on Dahl rat Chr 17, not including the Endothelin-1 gene (Edn1). The positive proofs came from two congenic strains, C17S.L1 and C17S.L2.
Proof of the presence of a BP QTL on Dahl rat Chr 17.
If such a BP QTL exists in the fragment between D17Rat97 and D17Rat181, it has to fulfill the following criteria. Multiple congenic strains sharing the same chromosome section had to show BP effects, whereas any other congenic strains not sharing it should not have BP effects. Indeed, this is the case. . Maps refer to physical (base pairs), radiation hybrid (cR), and linkage (cM) maps from left to right. The linkage map is essentially the same as has been published previously (6, 8, 12) . Oval bars to the left of the cR and cM maps represent base pairs on the physical map. They refer to the alignment of rat supercontigs in an ascending order from top to bottom on Chr 17, obtained by blasting a marker to the rat genome database (http://www.ncbi.nlm.nih.gov/genome/seq/RnBlast.html). The name of a supercontig starts with NW_0474, followed by 2-digit nos. Nos. below a supercontig indicate its approximate size in base pairs. Solid bars under congenic strains symbolize the Dahl salt-sensitive (DSS) chromosome fragments (open bar) that have been replaced by that of the Lewis (LEW) rat. Hatched bars on the ends of solid bars indicate the ambiguities of crossover breakpoints between markers. The rest of Chr 17 and the rest of the genome of each congenic strain are SS homozygous. Agtr1a, angiotensin receptor AT1A; Chrm3, acetylcholine receptor m3 muscarinic; Drd1a, dopamine 1A receptor; Edn1, endothelin-1; Prl, prolactin; Ryr2, cardiac isoform of the ryanodine receptor. The rest of the markers are anonymous [either from our current or previous work (6, 8, 12) or from the rat database http://www.genome.wi.mit.edu/ rat/public/]. Markers included inside parentheses are those not genotyped for a lack of polymorphisms between DSS and LEW. Their placements were done based on their chromosome locations only (6, 8, 12, 28) . Primers (5Ј to 3Ј, forward and reverse) for new markers are as follows: D17Chm2, gagcaggaactggtctcattg and tgccatgacattggctaaaa; D17Chm9, cagatggtcaatgtgacagga and cctctgacttctggcctaca; D17Chm14, gcagatcaggcagggagtta and caggaggcagaagcatttgt; D17Chm19, tagtgcccagcaattgtgtc and gccatctgttgtgtgttgct; D17Chm26, ggtcaacgatgcaaaagaca and aaggtggtggattaccttgg; and D17Chm55, cagcagcccatcactgtaaa and aaagtttggtccccagtgtg. Congenic strains are DSS.LEW-(D17Rat65-Prl)/Lt (abbreviated as C17S.L1), DSS.LEW-(D17Chm14/D17Rat83)/Lt (abbreviated as C17S.L2), DSS.LEW-(D17Rat65/D17Chm2)/Lt (abbreviated as C17S.L3), DSS.LEW-(D17Chm9/D17Rat97)/Lt (abbreviated as C17S.L4), and DSS.LEW-(D17Chm14/ D17Rat97)/Lt (abbreviated as C17S.L5). Placement of the QTL is indicated by a bracket to the right of the congenic strains. The chromosome coverage from our previous work (12) is indicated to the extreme right under Ref. 12 . Mean arterial pressures (MAPs) at bottom refer to those averaged throughout the period of measurements, in mmHg, for the strains above; n indicates the no. of animals used.
C17S.L1 and C17S.L2 clearly demonstrated BP effects, and they have one segment between D17Chm2 and D17Rat181 in common (Fig. 1) . In contrast, C17S.L3, C17S.L4, and C17S.L5 possess the same genome constitutions as C17S.L1 and C17S.L2 except for the LL congenic regions in question (Fig.  1) , and they did not manifest BP effects. By comparing the chromosome interval shared between C17S.L1 and C17S.L2, which is not in common with C17S.L3, C17S.L4, and C17S.L5, one can further narrow the region harboring the QTL to the segment between D17Rat97 and D17Rat181 (i.e., excluding the section between D17Chm2 and D17Rat97). Moreover, a lack of BP effects in C17S.L3, C17S.L4, and C17S.L5 proves also that the BP effects observed in C17S.L1 and C17S.L2 can be directly attributed to the QTL present in the region between D17Rat97 and D17Rat181 and were not due to the influence from the rest of the genome. Therefore, during the process of congenic constructions, the residual genetic background from LEW, if any, could not have lowered BPs observed in C17S.L1 and C17S.L2.
Because the region harboring the QTL is ϳ15 cM (Fig. 1) , it is still too large for positional cloning to identify the QTL. One way to narrow the region is by fine mapping with congenic substrains involving smaller chromosome intervals within acetylcholine receptor m3 muscarinic (Chrm3) and Prl. During the process of screening crossovers to derive congenic substrains from C17S.L1, of the nine rats found, only one showed a crossover between Chrm3 and Prl. This rat subsequently died before breeding could take place. Thus no substrain was derived from it. One reason of a scarcity of crossovers detected in the region between Chrm3 and Prl could be due to the presence of a crossover "cold" region, among other factors.
Comparisons with our previous results. How would one explain that our original congenic strain (12) , congenic 1, failed to exhibit a BP effect? This could be due to one or a combination of the following reasons.
First, the region of crossover ambiguity in congenic 1 (12) overlaps with the region of C17S.L4 and C17S.L5 in our current work. These regions are shown as hatched bars in the top section of Ref. 12 and the bottom sections for C17S.L4 and C17S.L5 in Fig. 1 . More precisely, the crossover regions of ambiguity in the two different studies still had in common the segment between D17Rat97 and Chrm3, which is 184.2 Ϫ 168.7 ϭ 15.5 cR, or 1.8 megabases in size. The QTL could fall in this gap. It would be interesting to define more precisely the crossover break point in congenic 1 (12) . This could be done by genotyping all the markers located between D17Mit5 and Chrm3, as shown in Fig. 1, in congenic 1 . Unfortunately, our research group at CHUM did not have available the genomic DNA samples from congenic 1 to resolve this issue, because it was produced in collaboration with the laboratory of Dr. J. P. Rapp at the Medical College of Ohio.
Second, congenic 1 (12) was constructed by the conventional method (23), i.e., only selecting for several Chr 17 markers, whereas our present congenic strains were selected based on a total genomic scan. Consequently, there could be some undefined residual heterozygosity or even homozygosity from the LEW genome remaining in congenic 1 (12) . Without the benefit of a total genome scan and a negative control congenic strain, it remains unknown whether a QTL(s) from another chromosome region(s) could have any additive or suppressive influence on the expression of the QTL on Chr 17, assuming that it was trapped in congenic 1. In contrast, the QTL-residing segment defined in our current work was proven in two "positive" congenic strains, C17S.L1 and C17S.L2. The remaining genetic background was ruled out to have any influence on BP shown from the QTL by three negative congenic strains, C17S.L3, C17S.L4, and C17S.L5.
Third, it cannot be excluded that there exists a potential strain difference between the LEW rats used in the two independent studies. Both LEW strains are inbred and were purchased from Charles River Laboratories [at Wilmington, MA, previously (12) and at La Salle, Quebec, Canada, in our current work]. Despite this nomenclature similarity, there is no information on a possible genetic divergence in Chr 17 QTL alleles in the strain between the two different sources.
Finally, a technical difference in BP measurements could have resulted in different results. The BP measurements conducted previously were by tail cuff (12) , whereas those in our current work were by telemetry. Although differences in these two methods were evident (5), the results in mapping BP QTLs using these two differing methods seem to be consistent. For example, in mapping multiple QTL on Dahl Chr 10, the tail cuff (13) and telemetry (7, 24) methods produced similar results. The possibility, however, cannot be completely excluded that these two methods could lead to differing results in QTL mapping.
In perspective, although the Edn1 is located on the outside of the QTL interval (Fig. 1) , there are two genes that can be considered, potentially, as the candidate. They are the genes for the angiotensin II receptor AT1A (Agtr1a) (25) and a cardiac isoform of the ryanodine receptor (Ryr2) (28) (Fig. 1) . Because no polymorphic markers were found for Ryr2 and Agtr1a (indicated by parentheses in Fig. 1 ), they were not genotyped in the congenic strains. Their placements on the map were based solely on their locations with reference to other markers (6, 8, 12, 28) .
At this point of writing, there are no other substrains available to cover more narrowly the segment harboring the QTL between Chrm3 and Prl. However, because the QTL-containing interval is ϳ15 cM (Fig. 1) , fine mapping by congenic substrains will be necessary for further reductions in the future. Barring the presence of a possible crossover cold spot, as our recent work (21) as well as that of other investigators (14) has demonstrated, it is possible to narrow a QTL interval to 1-2 cM or smaller. Then, one can test the candidacy of either Agtr1a or Ryr2 more precisely. On the basis of our previous work, it appears more definitive to rule out a candidate gene when a congenic strain harboring it lacks a BP effect than to prove it as a QTL. The genes coding for angiotensin-converting enzyme (Ace) and the inducible form of nitric oxide synthase (Nos2) are cases in point (21) . Moreover, fine mapping will also address the issue of whether there would be more than one QTL present in the region (Fig. 1) . If no candidate genes are present in the QTL interval of 1-2 cM, positional cloning would be used (4, 5, 16) .
In conclusion, a systematic congenic strategy was utilized to produce two congenic strains exhibiting BP effects and, as controls, three congenic strains lacking BP effects. This congenic mapping approach provided physical evidence that a BP QTL is present in a segment of ϳ15 cM on Dahl Chr 17. With the rat genome-wide sequence now available (15) , further fine congenic mapping and a mutation screening will be greatly facilitated on genes found in the QTL interval (4) . The QTL region is homologous to a section of mouse Chr 13 and sections of human CHR1 and CHR6 (http://www.ncbi.nlm. nih.gov/). The QTL, once identified, could be used to study human essential hypertension (4, 5) .
